Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0555198|malignant glioma |
Sentences | 1 |
PubMedID- 19669096 | This multicenter phase ii study conducted by the spanish neuro-oncology group evaluated the activity of an extended, dose-dense temozolomide regimen in patients with temozolomide-refractory malignant glioma. |
Page: 1